David Meininger

1.5k citations

22 papers · 1.2k indexed · h-index 19

Impact in

Biological Psychiatry top 5%
- Tryptophan and brain disorders
Behavioral Neuroscience top 10%

Papers in

Biological Psychiatry 2
- Tryptophan and brain disorders 2
Behavioral Neuroscience 2
- Stress Responses and Cortisol 2

Co-authors: Elizabeth A. Komives Christopher E. White Sophia Siu Nigel P.C. Walker Michael J. Hunter Maurizio Pellecchia Daniel S. Sem R M Jack
Journals: Protein Science (3 papers)Biochemistry (3 papers)Molecular Cancer Therapeutics (1 paper)Journal of the American Chemical Society (1 paper)Journal of Biomolecular NMR (1 paper)
Partner nations: United States Canada Switzerland

In The Last Decade

David Meininger

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by David Meininger

Since Specialization

Citations

This map shows the geographic impact of David Meininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meininger more than expected).

Fields of papers citing papers by David Meininger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Meininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meininger. The network helps show where David Meininger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David Meininger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Meininger Line = papers co-authored together David Meininger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma Molecular Cancer Therapeutics ·Kevin J. Hamblett, Carl J. Kozlosky, Sophia Siu, Wesley Chang, Hua Liu, Ian N. Foltz, Esther S. Trueblood, David Meininger, Taruna Arora, Helmut Koch, Steven Vonderfecht, Qing Chen, John S. Hill, William C. Fanslow	2015	82
2	Agonistic Human Antibodies Binding to Lecithin-Cholesterol Acyltransferase Modulate High Density Lipoprotein Metabolism Journal of Biological Chemistry ·Ruwanthi N. Gunawardane, Scott Jacobson, Derek E. Piper, Shih-Hao Yang, Sophia Siu, Dongming Liu, Rosdwiana Putri Dewi, Mei Lü, Jie Tang, Kadda Azzaoui, Janet Cheng, Andrew J. Gates, David Meininger, Joyce Chan, Quinn D. Kellerman, Nigel P.C. Walker, Margrit Schwarz, John Delaney, Mingyue Zhou	2015	25
3	The high-resolution crystal structure of human LCAT Journal of Lipid Research ·Derek E. Piper, William G. Romanow, Ruwanthi N. Gunawardane, Scott Jacobson, Shih-Hao Yang, Oscar Pan, Stephen T. Thibault, Richard Zhang, David Meininger, Margrit Schwarz, Zhulun Wang, Chadwick King, Mingyue Zhou, Mohd. Ishak Mohd Yunos.	2015	37
4	Molecular Basis of Sphingosine Kinase 1 Substrate Recognition and Catalysis Structure ·Zhulun Wang, Xiaoshan Min, Shou-Hua Xiao, Sheree Johnstone, William G. Romanow, David Meininger, Haoda Xu, Jinsong Liu, Jessica Dai, Songzhu An, Eva Calvet, Nigel P.C. Walker	2013	146
5	Developability studies before initiation of process development mAbs ·Xiaoyu Yang, Wei Xu, Pedro Fern ndez de la Vega, Sabrina A. Benchaar, Leonardo Fonte, Valentyn Antochshuk, Jason K. Cheung, Mo Jesús Arranz, M. V. Rogova, Jason L. Rowand, Rico C. Gunawan, Alexander McCampbell, Maribel Beaumont, David Meininger, Daisy Richardson, Alexandre Ambrogelly	2013	90
6	Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·David Meininger, Leeanne Zalameda, Yichin Liu, Lara Stepan, Luís Borges, John D. McCarter, Claire L. Sutherland	2011	88
7	In Vitro Modulation of Cytochrome P450 Reductase Supported Indoleamine 2,3-Dioxygenase Activity by Allosteric Effectors Cytochromeb₅and Methylene Blue Biochemistry ·Josh T. Pearson, Sophia Siu, David Meininger, Larry C. Wienkers, Dan A. Rock	2010	24
8	Fusion partners can increase the expression of recombinant interleukins via transient transfection in 2936E cells Protein Science ·Jane Carter, Jue Zhang, Z Surmacz, Haruki Hasegawa, Janet Cheng, Juan Carlos Martín Baranda, Jason O’Neill, Martin F. Wolfson, Sophia Siu, Alicia Bond, David Meininger, Helen Kim, John Delaney, Christopher Mehlin	2009	22
9	The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 Cytokine ·Gaby Palmer, Brian P. Lipsky, Molly D. Smithgall, David Meininger, Sophia Siu, Dominique Talabot‐Ayer, Cem Gabay, Dirk E. Smith	2008	150
10	Distinctive molecular inhibition mechanisms for selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 Bioorganic & Medicinal Chemistry ·Hua Tu, Jay P. Powers, Jinsong Liu, I. Golutvin, Athena Sudom, Xuelei Yan, Haoda Xu, David Meininger, Caroline Kovarski, Xiaodong He, Juan C. Jaén, Daqing Sun, Marc Labelle, Hiroshi Yamamoto, Bei Shan, Nigel P.C. Walker, Zhulun Wang	2008	30
11	Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers Biochemical Journal ·Sylvia Herter, Derek E. Piper, Wade H. Aaron, Faiza Camila, Gene Cutler, Ping Cao, Ami S. Bhatt, Youngchool Choe, Charles S. Craik, Nigel P.C. Walker, David Meininger, Timothy Hoey, Richard J. Austin	2005	152
12	Systems-Based Design of Bi-Ligand Inhibitors of Oxidoreductases Chemistry & Biology ·Daniel S. Sem, Ma. Michaella Faye L. Carvajal, Inez Rosalinda Soares, Luke Pollock, Hande Doğruyol, Stephen M. Coutts, Qing Dong, Mark R. Hansen, Victor Sukbong Hong, Xuemei Huang, Richard M. Jack, Itsumure Nishiyama, Martin Greve, Chen-Ting Ma, David Meininger, Maurizio Pellecchia, Fabrice H.F. Pierre, Hugo O. Villar, H. Raudenbusch	2004	29
13	NMR-based structural characterization of large protein-ligand interactions Journal of Biomolecular NMR ·Maurizio Pellecchia, David Meininger, Qing Dong, Luke Pollock, R M Jack, Daniel S. Sem	2002	86
14	Characterization of the Binding Interface between the E-Domain of Staphylococcal Protein A and an Antibody Fv-Fragment Biochemistry ·David Meininger, Mark Rance, Melissa A. Starovasnik, Wayne J. Fairbrother, Nicholas J. Skelton	2000	1
15	Characterization of the Binding Interface between the E-Domain of Staphylococcal Protein A and an Antibody Fv-Fragment Biochemistry ·David Meininger, Mark Rance, Melissa A. Starovasnik, Wayne J. Fairbrother, Nicholas J. Skelton	1999	23
16	Generation of Protease-Deficient Strains and Their Use in Heterologous Protein Expression Methods in molecular biology ·Martin A. Gleeson, Christopher E. White, David Meininger, Elizabeth A. Komives	1998	72
17	Structure of the fifth EGF-like domain of thrombomodulin: an EGF-like domain with a novel disulfide-bonding pattern 1 1Edited by P. E. Wright Journal of Molecular Biology ·Shimaa A. Shaaban, Michael J. Hunter, David Meininger, Elizabeth A. Komives	1997	26
18	Synthesis, activity, and preliminary structure of the fourth EGF-like domain of thrombomodulin Protein Science ·David Meininger, Michael J. Hunter, Elizabeth A. Komives	1995	17
19	Thrombin inhibition by cyclic peptides from thrombomodulin Protein Science ·Julie C. Lougheed, Pamela M. Zimmerman-Owen, David Meininger, Elizabeth A. Komives	1995	14
20	Large-scale expression, purification and characterization of small fragments of thrombomodulin: the roles of the sixth domain and of methionine 388 Protein Engineering Design and Selection ·Christopher E. White, Michael J. Hunter, David Meininger, Park Sang Kun, Elizabeth A. Komives	1995	59

About David Meininger

David Meininger is a scholar working on Biological Psychiatry, Behavioral Neuroscience, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Enzyme Structure and Function (3 papers), Glycosylation and Glycoproteins Research (2 papers), Stress Responses and Cortisol (2 papers), Protein purification and stability (2 papers), Biochemical and Structural Characterization (2 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Biological Psychiatry (98 citations), Behavioral Neuroscience (44 citations), Immunology (216 citations), Molecular Biology (689 citations) and Radiology, Nuclear Medicine and Imaging (192 citations). David Meininger has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Elizabeth A. Komives, Christopher E. White, Sophia Siu, Nigel P.C. Walker, Michael J. Hunter, Maurizio Pellecchia, Daniel S. Sem, R M Jack, Brian P. Lipsky and Molly D. Smithgall. Their work appears in journals such as Protein Science, Biochemistry, Molecular Cancer Therapeutics, Journal of the American Chemical Society and Journal of Biomolecular NMR.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact